Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details Narrative)

v3.7.0.1
NON CONTROLLING INTEREST (Details Narrative)
Jul. 28, 2016
Brady Granier, Lourdes Felix and Kent Emry [Member]  
Sub issued ownership percentage 21.90%
BioCorRx Pharmaceuticals, Inc [Member]  
Company holds ownership percentage 78.10%